CISATRACURIUM ACCORD cisatracurium (as besilate) 5 mg /2.5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 5 mg /2.5 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 6.7 mg (equivalent: cisatracurium, qty 5 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 20 mg /10 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 20 mg /10 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 26.8 mg (equivalent: cisatracurium, qty 20 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 50 mg / 25 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 50 mg / 25 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 67 mg (equivalent: cisatracurium, qty 50 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

CISATRACURIUM ACCORD cisatracurium (as besilate) 10 mg / 5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium accord cisatracurium (as besilate) 10 mg / 5 ml solution for injection vial

accord healthcare pty ltd - cisatracurium besilate, quantity: 13.4 mg (equivalent: cisatracurium, qty 10 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit

ATRACURIUM BESYLATE INJECTION LIQUID Canada - English - Health Canada

atracurium besylate injection liquid

sandoz canada incorporated - atracurium besylate - liquid - 10mg - atracurium besylate 10mg - miscellaneous skeletal muscle relaxants

Atracurium besilate 10 mg/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

atracurium besilate 10 mg/ml solution for injection/infusion

as kalceks - atracurium besilate - solution for injection/infusion - 10 milligram(s)/millilitre - other quaternary ammonium compounds; atracurium

Cisatracurium Accord Healthcare 2 mg/ml inj./inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cisatracurium accord healthcare 2 mg/ml inj./inf. sol. i.v. vial

accord healthcare b.v. - cisatracurium besilate 2,68 mg/ml - eq. cisatracurium 2 mg/ml - solution for injection/infusion - 2 mg/ml - cisatracurium besilate 2.68 mg/ml - cisatracurium